Cofertility vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cofertility matches women who want to freeze eggs for their future with intended parents who need donor eggs, reducing the cost of freezing by sharing eggs with recipients.
About
Cofertility is a fertility technology company founded in 2021 that has created a unique egg sharing model connecting women who want to freeze their eggs with intended parents who need donor eggs. Through the platform's Split program, egg donors freeze half of their eggs for their own future use while the other half goes to recipients, with the recipient paying for the donor's entire egg freezing cycle. This arrangement makes egg freezing free for donors who would otherwise pay $10,000 or more out of pocket, while providing recipients with a younger, more diverse egg donor pool. Cofertility raised $30M and has built the largest technology-first egg donation platform, emphasizing donor safety, informed consent, and transparent compensation practices that differ from traditional egg donation agencies. The company screens donors and handles all clinical coordination with partner fertility clinics. Cofertility addresses both the financial barrier to egg freezing that prevents many women from accessing this preventive care and the limited supply of diverse egg donors that many intended parents face. The platform represents a novel market structure that creates value for donors, recipients, and the overall fertility ecosystem simultaneously.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.